Covered recipient · General Payments record
CHANUN D PARK
Allopathic & Osteopathic Physicians Internal Medicine
This page merges CMS profile IDs 11423896, 27608 — associated profiles published by CMS for the same covered recipient. See the colophon below.
General Payments · PY2018–2022
$1,549.27
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $151.44 | 8 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $64.79 | 3 |
| Novo Nordisk AS | $18.53 | 1 |
| Lilly USA, LLC | $18.52 | 1 |
| PFIZER INC. | $18.19 | 1 |
| Astellas Pharma US Inc | $15.71 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $15.71 | 10/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940310791 | CMS |
| GlaxoSmithKline, LLC. | $21.72 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944765959 | CMS |
| GlaxoSmithKline, LLC. | $24.78 | 09/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944765951 | CMS |
| GlaxoSmithKline, LLC. | $18.29 | 10/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944765955 | CMS |
| Lilly USA, LLC | $18.52 | 08/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917940815 | CMS |
| Novartis Pharmaceuticals Corporation | $15.70 | 08/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894201749 | CMS |
| Novo Nordisk Inc | $18.53 | 08/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898560019 | CMS |
| PFIZER INC. | $18.19 | 08/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949216581 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
- Merged CMS profile IDs
- 11423896, 27608
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.